In biology, the binding of cellular proteins to molecules called ligands produces myriad functions essential for life, ...

Our work has generated investment ideas in health care, consumer electronics, finance technologies, transportation, AI-based Oppenheimer raised the firm’s price target on Ligand (LGND ...

University of Missouri researchers and collaborators have developed a new chemical tool that could help lower the cost of ...

University of Missouri researchers and collaborators have developed a new chemical tool that could help lower the cost of ...

Oppenheimer raised the firm’s price target on Ligand (LGND) to $151 from $135 and keeps an Outperform rating on the shares following the company’s investor day. Key takeaways, the firm says ...

The ability to alter protein binding can create tailored therapeutics with reduced side effects, sensitive diagnostic tools, ...

Hantz Financial Services Inc. acquired a new position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) during the fourth quarter, according to the company in its most recent filing ...

Epidermal growth factor receptor (EGFR) is a major driver of cancer dissemination and target for anti-cancer therapies but ...

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and ...

Researchers have developed a new chemical tool that could help lower the cost of prescription medications. The tool, called AshPhos, is a ligand, or molecule, that makes it easier to create special ...